Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2000, Greenleaf Ventures is a U.S.-based investment firm co-founded by Timothy Stocksdale and David Wallace. The firm specializes in control equity investments in healthcare companies, with a portfolio of seven companies and a focus on driving sustainable growth. Greenleaf Ventures has extensive experience in founding, scaling, and selling healthcare businesses.
Greenleaf Ventures invests $10M to $50M in pre-seed, seed, and growth equity stages, primarily in healthcare, digital health, biotech, and consumer sectors. The firm targets established businesses, providing not just capital but also operational expertise to enhance growth and innovation.
Notable companies in Greenleaf Ventures' portfolio include Aptiva Medical, a provider of continuous glucose monitoring devices; AptivaRx, a specialty online pharmacy; and Sterling Distributors, which focuses on medical supplies. Exited companies include Access Diabetic Supply, AmeriMedRx, Arriva Medical, and Comfort Medical.
Submit your pitch through their form at greenleafventures.com.
Yes, Greenleaf Ventures often leads investment rounds, particularly in their focus sectors of healthcare and biotech.
The firm is open to follow-on investments, especially in companies where they have already established a strong partnership and see potential for further growth.
Greenleaf Ventures manages a fund size that allows for investments ranging from $10M to $50M, focusing on established healthcare businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.